The Influence of Akkermansia Muciniphila on Intestinal Barrier Function

Overview

Journal Gut Pathog

Publisher Biomed Central

Specialty Gastroenterology

Date 2024 Aug 3

PMID 39097746

Authors

Chunyan Mo

Xiran Lou

Jinfang Xue

Zhuange Shi

Yifang Zhao

Fuping Wang

Guobing Chen

Affiliations

Soon will be listed here.

Abstract

Intestinal barriers play a crucial role in human physiology, both in homeostatic and pathological conditions. Disruption of the intestinal barrier is a significant factor in the pathogenesis of gastrointestinal inflammatory diseases, such as inflammatory bowel disease. The profound influence of the gut microbiota on intestinal diseases has sparked considerable interest in manipulating it through dietary interventions, probiotics, and fecal microbiota transplantation as potential approaches to enhance the integrity of the intestinal barrier. Numerous studies have underscored the protective effects of specific microbiota and their associated metabolites. In recent years, an increasing body of research has demonstrated that Akkermansia muciniphila (A. muciniphila, Am) plays a beneficial role in various diseases, including diabetes, obesity, aging, cancer, and metabolic syndrome. It is gaining popularity as a regulator that influences the intestinal flora and intestinal barrier and is recognized as a 'new generation of probiotics'. Consequently, it may represent a potential target and promising therapy option for intestinal diseases. This article systematically summarizes the role of Am in the gut. Specifically, we carefully discuss key scientific issues that need resolution in the future regarding beneficial bacteria represented by Am, which may provide insights for the application of drugs targeting Am in clinical treatment.

Citing Articles

Rehydration Beverages Made from Infusion, Probiotics, and Prebiotics: Antioxidant and Anti-Inflammatory Potential.

Salas-Ramirez C, Moreno-Jimenez M, Rocha-Guzman N, Gallegos-Infante J, Gonzalez-Laredo R, Gonzalez Herrera S Foods. 2025; 14(5).

PMID: 40077540 PMC: 11898763. DOI: 10.3390/foods14050837.

Akkermansia muciniphila Akk11 Supplementation Attenuates MPTP-Induced Neurodegeneration by Inhibiting Microglial NLRP3 Inflammasome.

Wang W, Shi S, Su M, Li Y, Yao X, Jiang J Probiotics Antimicrob Proteins. 2025; .

PMID: 40048129 DOI: 10.1007/s12602-025-10499-1.

Big lessons from the little in hepatocellular carcinoma.

Yang Y, Shi X Front Immunol. 2025; 16:1524563.

PMID: 40028328 PMC: 11868108. DOI: 10.3389/fimmu.2025.1524563.

Characterization and Anti-Inflammatory Effects of -Derived Extracellular Vesicles.

Zhao S, Xiang J, Abedin M, Wang J, Zhang Z, Zhang Z Microorganisms. 2025; 13(2).

PMID: 40005829 PMC: 11858061. DOI: 10.3390/microorganisms13020464.

Modulation of the Neuro-Cancer Connection by Metabolites of Gut Microbiota.

Mafe A, Busselberg D Biomolecules. 2025; 15(2).

PMID: 40001573 PMC: 11853082. DOI: 10.3390/biom15020270.

References

Shao R, Yang Y, Zhang Y, Zhao S, Zheng Z, Chen G . The expression of thioredoxin-1 and inflammatory cytokines in patients with sepsis. Immunopharmacol Immunotoxicol. 2020; 42(3):280-285. DOI: 10.1080/08923973.2020.1755309. View

Gilroy R, Ravi A, Getino M, Pursley I, Horton D, Alikhan N . Extensive microbial diversity within the chicken gut microbiome revealed by metagenomics and culture. PeerJ. 2021; 9:e10941. PMC: 8035907. DOI: 10.7717/peerj.10941. View

Yoon H, Cho C, Yun M, Jang S, You H, Kim J . Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice. Nat Microbiol. 2021; 6(5):563-573. DOI: 10.1038/s41564-021-00880-5. View

Wang L, Tang L, Feng Y, Zhao S, Han M, Zhang C . A purified membrane protein from or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8 T cells in mice. Gut. 2020; 69(11):1988-1997. PMC: 7569398. DOI: 10.1136/gutjnl-2019-320105. View

Ndongo S, Armstrong N, Raoult D, Fournier P . Reclassification of eight Akkermansia muciniphila strains and description of Akkermansia massiliensis sp. nov. and Candidatus Akkermansia timonensis, isolated from human feces. Sci Rep. 2022; 12(1):21747. PMC: 9758162. DOI: 10.1038/s41598-022-25873-0. View

Peterson L, Artis D . Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol. 2014; 14(3):141-53. DOI: 10.1038/nri3608. View

Kuczma M, Szurek E, Cebula A, Ngo V, Pietrzak M, Kraj P . Self and microbiota-derived epitopes induce CD4 T cell anergy and conversion into CD4Foxp3 regulatory cells. Mucosal Immunol. 2020; 14(2):443-454. PMC: 7946630. DOI: 10.1038/s41385-020-00349-4. View

Si J, Kang H, You H, Ko G . Revisiting the role of as a therapeutic bacterium. Gut Microbes. 2022; 14(1):2078619. PMC: 9135416. DOI: 10.1080/19490976.2022.2078619. View

Derrien M, van Baarlen P, Hooiveld G, Norin E, Muller M, de Vos W . Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila. Front Microbiol. 2011; 2:166. PMC: 3153965. DOI: 10.3389/fmicb.2011.00166. View

10.

Van den Abbeele P, Gerard P, Rabot S, Bruneau A, El Aidy S, Derrien M . Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin-degradation in humanized rats. Environ Microbiol. 2011; 13(10):2667-80. DOI: 10.1111/j.1462-2920.2011.02533.x. View

11.

Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L . A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 2016; 23(1):107-113. DOI: 10.1038/nm.4236. View

12.

Ghosh S, Whitley C, Haribabu B, Jala V . Regulation of Intestinal Barrier Function by Microbial Metabolites. Cell Mol Gastroenterol Hepatol. 2021; 11(5):1463-1482. PMC: 8025057. DOI: 10.1016/j.jcmgh.2021.02.007. View

13.

Liu Y, Huang W, Wang J, Ma J, Zhang M, Lu X . Multifaceted Impacts of Periodontal Pathogens in Disorders of the Intestinal Barrier. Front Immunol. 2021; 12:693479. PMC: 8353228. DOI: 10.3389/fimmu.2021.693479. View

14.

Agus A, Planchais J, Sokol H . Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host Microbe. 2018; 23(6):716-724. DOI: 10.1016/j.chom.2018.05.003. View

15.

Hakansson A, Tormo-Badia N, Baridi A, Xu J, Molin G, Hagslatt M . Immunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice. Clin Exp Med. 2014; 15(1):107-20. PMC: 4308640. DOI: 10.1007/s10238-013-0270-5. View

16.

Alam A, Leoni G, Quiros M, Wu H, Desai C, Nishio H . The microenvironment of injured murine gut elicits a local pro-restitutive microbiota. Nat Microbiol. 2016; 1:15021. PMC: 5076466. DOI: 10.1038/nmicrobiol.2015.21. View

17.

Chang P, Hao L, Offermanns S, Medzhitov R . The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A. 2014; 111(6):2247-52. PMC: 3926023. DOI: 10.1073/pnas.1322269111. View

18.

Bunger M, van den Bosch H, van der Meijde J, Kersten S, Hooiveld G, Muller M . Genome-wide analysis of PPARalpha activation in murine small intestine. Physiol Genomics. 2007; 30(2):192-204. DOI: 10.1152/physiolgenomics.00198.2006. View

19.

Strowig T, Henao-Mejia J, Elinav E, Flavell R . Inflammasomes in health and disease. Nature. 2012; 481(7381):278-86. DOI: 10.1038/nature10759. View

20.

Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S . Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019; 25(7):1096-1103. PMC: 6699990. DOI: 10.1038/s41591-019-0495-2. View